Comparison results
| Results: Differences General | ✘Oligodendroglioma | ✘Ovarian androblastoma | |||||||
| Related research | Analogs | Analogs | |||||||
| |||||||||
| Distinctive symptoms | |||||||||
| Register, to see more distinctive signs of diseases and studies | 89% | — | |||||||
| Register, to see more distinctive signs of diseases and studies | — | 84% | |||||||
| brain tumor | 34% | — | |||||||
| increased hairiness | — | 53% | |||||||
| brain tumors | 29% | — | |||||||
| clitoris | — | 47% | |||||||
| main complaint headache | 29% | — | |||||||
| appendages of the uterus | — | 45% | |||||||
| women passion | 27% | — | |||||||
| uterine appendages are increase | — | 45% | |||||||
| very pale | 25% | — | |||||||
| hirsutism | — | 45% | |||||||
| effects of radiation | 23% | — | |||||||
| emaciation | — | 44% | |||||||
| oncology relatives | 22% | — | |||||||
| rapid weight loss | — | 44% | |||||||
| headache attacks | 22% | — | |||||||
| hair loss on the crown | — | 44% | |||||||
| speech absence | 22% | — | |||||||
| lack of menstruation | — | 41% | |||||||
| heredity predisposition | 20% | — | |||||||
| female pelvic organs | — | 41% | |||||||
| epilepsy attacks | 20% | — | |||||||
| vaginal discharge | — | 40% | |||||||
| irritability | 19% | — | |||||||
| ovarian tumors | — | 40% | |||||||
| epilepsy | 19% | — | |||||||
| monthly gas scanty | — | 39% | |||||||
| visual impairment | 19% | — | |||||||
| baldness in the frontal region | — | 37% | |||||||
| convulsions | 18% | — | |||||||
| bloody discharge from the vagina | — | 37% | |||||||
| impaired lung function | 17% | — | |||||||
| stopped menstruation | — | 36% | |||||||
| headaches | 17% | — | |||||||
| acne | — | 34% | |||||||
| impaired venous function | 17% | — | |||||||
| virile syndrome | — | 34% | |||||||
| attacks of pain | 17% | — | |||||||
| pimples on the face | — | 34% | |||||||
| onset of illness | 16% | — | |||||||
| receding hairline | — | 34% | |||||||
| consequences of taking medications | 15% | — | |||||||
| acne face | — | 33% | |||||||
| radiation damage | 26% | 18% | |||||||
| increased | — | 33% | |||||||
| oncology | 35% | 31% | |||||||
| ovarian apoplexy | — | 33% | |||||||
| rough voice | — | 33% | |||||||
| menstruation disorder | — | 31% | |||||||
| clitoromegaly | — | 31% | |||||||
| hypertrophy of the uterine body | — | 31% | |||||||
| pimples on the body | — | 30% | |||||||
| involution of the mammary glands | — | 30% | |||||||
| rashes on the face | — | 30% | |||||||
| monthly short | — | 28% | |||||||
| excess testesterone | — | 28% | |||||||
| appendages of pain | — | 27% | |||||||
| premature menstruation | — | 27% | |||||||
| vaginal discharge in girls | — | 27% | |||||||
| rupture of the uterus | — | 27% | |||||||
| altered voice | — | 26% | |||||||
| additional mammary gland | — | 26% | |||||||
| testesterone deficiency | — | 26% | |||||||
| removal of the uterine body | — | 25% | |||||||
| premature sexual development | — | 25% | |||||||
| rashes on the genitals | — | 25% | |||||||
| baldness | — | 24% | |||||||
| to increase the mammary glands | — | 24% | |||||||
| change in appetite | — | 24% | |||||||
| postmenopause | — | 24% | |||||||
| fat deposits | — | 23% | |||||||
| solid tumors | — | 23% | |||||||
| indecision | — | 22% | |||||||
| rash on the body | — | 22% | |||||||
| voice disorders | — | 22% | |||||||
| hair loss | — | 22% | |||||||
| skin problems | — | 22% | |||||||
| menopause | — | 22% | |||||||
| apoplexy | — | 22% | |||||||
| lowered | — | 21% | |||||||
| genital neoplasms | — | 21% | |||||||
| weight change | — | 20% | |||||||
| myocardial infarction | — | 20% | |||||||
| does not tolerate pain | — | 19% | |||||||
| general weakness | — | 19% | |||||||
| no appetite | — | 19% | |||||||
| muscle pain | — | 19% | |||||||
| aching | — | 18% | |||||||
| feeling of heat | — | 17% | |||||||
| necrosis | — | 17% | |||||||
| high temperature | — | 17% | |||||||
| history of surgery | 26% | 33% | |||||||
| cancer | 24% | 24% | |||||||
| radiation therapy | 19% | 19% | |||||||
| consequences of surgery | 17% | 17% | |||||||
| there are no complaints | 16% | 16% | |||||||
Instructions
Video
|